Replay available

argenx SE (ARGX) Q3 2023 Earnings Call

argenx SE (NASDAQ: ARGX) Q3 2023 earnings conference call, held 2023-10-31. Replay captured from the company's public earnings webcast.

Tue, October 31, 2023 at 8:30 AMendedReplay
argenx SE (ARGX) Q3 2023 Earnings Call

Hosted by

Featured presenters

Beth DelGiaco

Vice President, Global Head of Corporate Communications and Investor Relations

Tim van Harmeren

Chief Executive Officer

Carl Gubitz

Chief Financial Officer

Karen Massey

Chief Operating Officer

Yatin Sineya

Guggenheim Partners

Derek Akila

Wells Fargo

Thomas Smith

Learing Partners

James Gordon

J.P. Morgan

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Argenx Se.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.089 -- 00:00:03.210 Good morning. My name is Rob, and I will be your conference operator today. 00:00:03.210 -- 00:00:06.212 I would like to welcome everyone to the call. 00:00:06.212 -- 00:00:10.673 At this time, all lines have been placed on mute to prevent any background noise. 00:00:10.673 -- 00:00:14.115 After the speaker's remarks, there will be a question and answer session. 00:00:14.115 -- 00:00:17.656 If you would like to ask a question during this time, simply press star followed by the 00:00:17.656 -- 00:00:22.058 number one on your telephone keypad. If you would like to withdraw your question, again 00:00:22.058 -- 00:00:27.463 press star one. Thank you. I'd like to introduce Beth DelGiaco, Vice President, 00:00:27.463 -- 00:00:31.206 Global Head of Corporate Communications and Investor Relations. 00:00:31.206 -- 00:00:33.868 You may now begin your conference. 00:00:33.868 -- 00:00:38.242 Thank you, Operator. A press release was issued earlier today with our third quarter 00:00:38.242 -- 00:00:39.693 2023 00:00:39.693 -- 00:00:44.777 financial results and business update. This can be found on our website along with the 00:00:44.777 -- 00:00:49.901 presentation for today's webcast. Before we begin, I'd like to remind you on 00:00:49.901 -- 00:00:54.684 slide two that forward-looking statements may be presented during this call. 00:00:54.684 -- 00:00:59.687 These may include statements about our future expectations, clinical developments, 00:00:59.687 -- 00:01:05.110 regulatory timelines, the potential success of our product candidates, financial 00:01:05.110 -- 00:01:08.152 projections, and upcoming milestones. 00:01:08.152 -- 00:01:12.855 Actual results may differ materially from those indicated by these statements. 00:01:12.855 -- 00:01:1...